Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Apr 15, 2026
Why Is D-Wave Quantum Inc. (QBTS) Stock Up +9.52% Today?

Why Is D-Wave Quantum Inc. (QBTS) Stock Up +9.52% Today?

Key Takeaways

  • Shares of D-Wave Quantum Inc. (QBTS) are rising +9.52% in Wednesday's session, trading at $18.59 against a prior close of $16.97
  • The primary catalyst is the continued sector-wide rally following Nvidia's launch of "Ising" — the world's first family of open-source AI models designed to accelerate quantum computing — announced on World Quantum Day (April 14)
  • Ising models deliver up to 2.5× faster and 3× more accurate quantum error correction than the current open-source industry standard, a development that signals AI and quantum computing are converging in a commercially meaningful way
  • D-Wave CEO Alan Baratz's widely circulated comment that Nvidia "should be shaking in their boots" given D-Wave's energy efficiency edge has sustained bullish retail and institutional sentiment into a second consecutive session
  • Peer quantum names are surging alongside QBTS, confirming this is a sector-level event rather than a company-specific catalyst
  • Traders are focused on D-Wave's upcoming May 7, 2026 earnings as the next major event to validate the stock's re-rating

Opening Summary

D-Wave Quantum Inc. (QBTS) is a commercially deployed quantum computing company headquartered in Palo Alto, California. Founded in 1999, D-Wave operates a dual-platform strategy combining its commercially proven annealing quantum systems — used today by enterprise clients in logistics, finance, manufacturing, and life sciences — with a gate-model roadmap acquired through its purchase of Quantum Circuits Inc. earlier in 2026. The company is one of the few pure-play quantum computing names already generating production revenue from deployed systems.

In Wednesday's trading session, QBTS shares are up +9.52%, currently trading at $18.59 compared to a prior session close of $16.97. The move extends a powerful two-session surge rooted in Nvidia's landmark Ising AI model launch on World Quantum Day and carries forward bullish D-Wave-specific commentary from CEO Alan Baratz that drew widespread media attention. The broader quantum sector is rallying in tandem, with multiple peer names posting double-digit gains on the day.

Nvidia's Ising Launch: The Central Catalyst

The defining event driving quantum computing stocks this week was Nvidia's April 14 announcement of Ising — described as the world's first family of open-source AI models purpose-built to accelerate quantum computing hardware. Unveiled on World Quantum Day, Ising addresses two of the most persistent bottlenecks in quantum hardware development: calibration and error correction.

The Ising suite includes two components: Ising Calibration, a vision-language model that reduces quantum processor setup time from days to hours through automated continuous calibration; and Ising Decoding, a 3D convolutional neural network delivering up to 2.5× faster and 3× more accurate error correction than the existing open-source standard.  Nvidia's director of quantum product framed the announcement succinctly: "AI is becoming the control plane for quantum hardware."  For investors, the signal was unmistakable — the world's dominant AI infrastructure company is now actively engineering tools to make quantum computing viable at commercial scale.

World Quantum Day Amplifies Momentum

April 14 also marks the annual World Quantum Day, an internationally recognized initiative — timed to reflect the Planck constant (4.14 × 10⁻¹⁵ electron volt-seconds) — designed to raise public and institutional awareness of quantum technologies.  The confluence of this event with Nvidia's Ising announcement created a uniquely powerful narrative moment: quantum computing appeared not merely as a speculative future technology, but as an accelerating commercial reality validated by the world's most valuable semiconductor company.

D-Wave CEO Alan Baratz moved quickly to capitalize on the Nvidia tailwind, stating publicly that Nvidia "should be shaking in their boots" given D-Wave's demonstrated energy efficiency advantages in optimization workloads.  The soundbite gained traction across financial media and reinforced the view that D-Wave — with already-deployed annealing systems in production — is positioned as a near-term commercial beneficiary of the broader quantum infrastructure buildout, not merely a long-dated speculative play.

Sector-Wide Rally Confirms Quantum Theme

The move in QBTS is not an isolated event. Quantum computing peers are surging broadly on Wednesday, confirming that Nvidia's Ising announcement and World Quantum Day momentum represent a sector-level catalyst rather than any company-specific development. IONQ, which rang the closing bell at the New York Stock Exchange on April 14 as a symbolic milestone for the quantum computing industry, is advancing +12.74% to $40.32 in today's session.  The rally has also spread internationally, with quantum-linked names in South Korea, China, and Japan posting sharp gains following Nvidia's announcement.

Nvidia (NVDA) itself is trading roughly flat on the day at $197.37, underscoring that the quantum rally is thematic and sector-specific — investors are rotating into pure-play quantum names rather than simply bidding up the broader AI complex.

Market Context and Trading Activity

QBTS opened Wednesday at $18.49, quickly pushing to an intraday high of $18.84 before consolidating in the $18.50–$18.60 range.  Although raw volume of approximately 17.4 million shares through midday trails the 30-day average of roughly 26 million shares, the session began only hours ago and pace is consistent with an elevated intraday run rate, as the heavy volume from Tuesday's session — when QBTS printed roughly 43 million shares — set a high bar.

Technically, QBTS has now recovered sharply from its March 30 multi-month low near $12.75, staging a roughly 46% rebound in under three weeks.  The stock is now trading above its 50-day moving average of $17.48, a technically significant level that, if sustained at the close, would represent the first clean break above that indicator in several months — a development that typically attracts additional momentum-oriented buyers. The 200-day moving average of $22.40 remains the next meaningful resistance overhead.

Trending AI Robots

For traders looking to systematically navigate high-momentum situations like the current quantum computing surge, Tickeron's Trending AI Robots page offers a curated, performance-ranked selection of the platform's strongest automated trading bots under current market conditions. Tickeron operates hundreds of AI-powered trading bots spanning thousands of tickers — covering strategies from trend-following and breakout trading to mean reversion and sector rotation, each with distinct timeframes, risk parameters, and performance metrics. Rather than listing every available bot, the Trending AI Robots section surfaces only those demonstrating the strongest recent results given prevailing market dynamics, making it practical to identify bots aligned with live conditions. Whether navigating explosive momentum plays in quantum computing or seeking a more systematic approach to volatile high-growth sectors, the Trending AI Robots page is a productive starting point for traders seeking an AI-driven edge.

What Comes Next for QBTS

D-Wave's next major event is its Q1 2026 earnings release, expected around May 7, 2026. Management will need to substantiate earlier commentary that 2026 sales activity already surpassed the entirety of 2025 within just the first quarter — a claim that carries significant weight at current valuation multiples.  Investors will be closely watching revenue recognition from previously announced deals, including a $20 million hardware sale to Florida Atlantic University and a $10 million enterprise quantum-computing-as-a-service contract with a Fortune 100 company.

Beyond earnings, the ongoing integration of Quantum Circuits Inc. and deployment milestones for the Advantage2 system will shape the medium-term narrative. Any incremental government contract announcements — particularly given the Trump administration's stated interest in accelerating domestic quantum computing development — could serve as additional near-term catalysts for QBTS. On the risk side, the stock's elevated price-to-sales multiple and continued net losses mean execution must remain flawless; any revenue shortfall or delay in commercial deployments would likely be punished disproportionately given the valuation premium the market is assigning to the quantum narrative.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: QBTS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


QBTS's Stochastic Oscillator sits in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +1.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where QBTS advanced for three days, in 166 of 195 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QBTS as a result. In 60 of 67 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for QBTS turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In 31 of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QBTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for QBTS entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. QBTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.882) is normal, around the industry mean (7.187). P/E Ratio (0.000) is within average values for comparable stocks, (51.474). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. QBTS's P/S Ratio (476.190) is very high in comparison to the industry average of (51.774).

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QBTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are Dell Technologies (NYSE:DELL), Arista Networks Inc (NYSE:ANET), Seagate Technology Holdings PLC (NASDAQ:STX), Western Digital Corp (NASDAQ:WDC), HP (NYSE:HPQ), 3D Systems Corp (NYSE:DDD).

Industry description

Computer Processing Hardware industry produces central processing unit, monitor, keyboard, computer data storage devices, and graphics card. Business activity and economic growth are potential drivers of this industry – if more businesses are growing or flourishing, so would their investments in computer equipment. Dell Technologies, Inc, Hewlett Packard Enterprise Co., NCR Corporation are key producers of computer processing hardware.

Market Cap

The average market capitalization across the Computer Processing Hardware Industry is 31.54B. The market cap for tickers in the group ranges from -0.18 to 345.52B. DELL holds the highest valuation in this group at 345.52B. The lowest valued company is HAUP at -0.18.

High and low price notable news

The average weekly price growth across all stocks in the Computer Processing Hardware Industry was 3%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 39%. QTEX experienced the highest price growth at 124%, while XTND experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Computer Processing Hardware Industry was 87%. For the same stocks of the Industry, the average monthly volume growth was 68% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 65
Price Growth Rating: 53
SMR Rating: 80
Profit Risk Rating: 86
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
QBTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ComputerProcessingHardware

Industry
N/A
Address
2650 East Bayshore Road
Phone
+1 650 285-28812
Employees
382
Web
https://www.dwavequantum.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.